文献速递多重用药衰弱、肌少症与跌倒

多重用药与社区老年人步态表现的关系

Polypharmacy and Gait Performance in Community-dwelling Older Adults.
PubMed 文献 · J Am Geriatr Soc · 2017-06-26

横断面研究纳入482名社区老年人,比较使用5种及以上和8种及以上药物与无多重用药者的步态速度。多重用药者简单行走和边走路边说话时速度更慢,校正年龄、性别、教育后差异显著,但校正共病后5种以上药物组差异不再显著,8种以上组仍部分显著,提示多重用药与步态关联仅部分由共病解释。

要点

  • 多重用药与步态速度的关联仅部分由共病解释,临床应关注多重用药老年人的步态表现。

核心结论

  • 多重用药与社区老年人步态速度下降相关,共病仅部分解释该关联。

研究设计与样本

  • 横断面研究,纳入482名社区居住老年人,比较使用5种及以上和8种及以上药物与无多重用药者的步态速度。

主要发现

  • 使用≥5种药物者164人(34%),较无多重用药者年龄更大(77.0±6.6 vs 76.0±6.4),更常见高血压、充血性心力衰竭、糖尿病、心肌梗死、更高BMI及过去一年跌倒史。

关键数值与推荐

  • 多重用药定义为使用5种及以上药物,并采用队列特异性替代定义8种及以上药物。
  • 步态速度(cm/s)在简单行走和边走路边说话条件下定量测量。

临床怎么用

  • 对社区多重用药老年人,尤其是使用8种及以上药物者,应关注步态速度下降风险。
  • 多重用药与步态关联仅部分由共病解释,提示药物管理可能有助于维持步态功能。

局限性

  • 横断面设计无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the relationship between polypharmacy and gait performance during simple (normal walk (NW)) and complex (walking while talking (WWT)) locomotion. DESIGN: Cross-sectional. SETTING: Community. PARTICIPANTS: Community-dwelling older adults (N = 482). MEASUREMENTS: Polypharmacy, defined as use of five or more medications and a cohort-specific alternate definition of eight or more medications, was examined. Velocity (cm/s) measured quantitatively during NW and WWT conditions. RESULTS: The 164 participants (34%) with polypharmacy of five or more medications were older (77.0 ± 6.6 vs 76.0 ± 6.4) and more likely to have hypertension, congestive heart failure, diabetes mellitus, myocardial infarction, and higher body mass index (BMI) and to have fallen within the last year than the remaining 318 without polypharmacy and walked 6 cm/s slower (P = .004) during NW and 4 cm/s slower during WWT (P = .07), adjusting for age, sex, and education. Group differences were not statistically significant after adjusting for comorbidities. Prevalence of polypharmacy of eight or more medications was 10%. This group walked 11 cm/s slower during NW (P < .001) and 8.6 cm/s slower during WWT (P = .01) than those without polypharmacy, adjusted for age, sex, and education. Participants taking eight or more medications had slower NW (8.5 cm/s; P = .01), and WWT (6.9 cm/s; P = .07), compared to those without polypharmacy, adjusting for comorbidities. Adjustments for BMI, high-risk drugs, falls, and comorbidities yielded slower NW (9.4 cm/s, P = .005) and WWT (7.9 cm/s, P = .04 among those with polypharmacy compared to those without polypharmacy). CONCLUSION: These results suggest an association between polypharmacy and locomotion that medical comorbidities only partly explained.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. George C, Verghese J. Polypharmacy and Gait Performance in Community-dwelling Older Adults. J Am Geriatr Soc. 2017. PMID: 28649786. doi:10.1111/jgs.14957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。